Abstract
Amide bond formation is one of the most important reactions in pharmaceutical synthetic chemistry. The development of sustainable methods of amide bond formation, including those that are catalyzed by enzymes, is therefore of significant interest. The ATP-dependent amide bond synthetase (ABS) enzyme McbA, from Marinactinospora thermotolerans, catalyzes the formation of amides as part of the biosynthetic pathway towards the marinacarboline secondary metabolites. The reaction proceeds via an adenylate intermediate, with both adenylation and amidation steps catalyzed within one active site. In this study, McbA has been applied to the synthesis of pharmaceutical-type amides from a range of aryl carboxylic acids with partner amines provided at 1-5 molar equivalents. The structure of McbA has revealed the structural determinants of aryl acid substrate tolerance and differences in conformation associated with the two half-reactions catalyzed. The catalytic performance of McbA, coupled with the structure, suggest that this and other ABS enzymes may be engineered for applications in the sustainable synthesis of pharmaceutically relevant (chiral) amides.
Original language | English |
---|---|
Pages (from-to) | 11584-11588 |
Number of pages | 5 |
Journal | Angewandte Chemie International Edition |
Volume | 57 |
Issue number | 36 |
Early online date | 23 Jul 2018 |
DOIs | |
Publication status | Published - 3 Sept 2018 |
Bibliographical note
© 2018 Wiley-VCH Verlag GmbH &Co. KGaA,Weinheim. This is an author-produced version of the published paper. Uploaded in accordance with the publisher’s self-archiving policy. Further copying may not be permitted; contact the publisher for details.Keywords
- ATP
- adenylation
- amides
- biocatalysis
- ligases